View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
May 25, 2011

Study Says Vectra DA Blood Test Effective for Rheumatoid Arthritis

Crescendo Bioscience has announced that Vectra DA, a first-in-class multi-biomarker blood test, can track rheumatoid arthritis activity and provide physicians with a measure to determine whether patients are responding to therapy. Its studies have confirmed that Vectra DA has the abili

By cms admin

Crescendo Bioscience has announced that Vectra DA, a first-in-class multi-biomarker blood test, can track rheumatoid arthritis activity and provide physicians with a measure to determine whether patients are responding to therapy.

Its studies have confirmed that Vectra DA has the ability to quantify and track rheumatoid arthritis activity, and can discriminate between low disease activity and remission within two weeks.

Vectra DA also predicts progressive joint damage and common co-morbid conditions in patients with rheumatoid arthritis.

Stephen Paget, physician-in-chief emeritus at the Hospital for Special Surgery in New York, said that the data indicated that Vectra DA can provide physicians with a molecular monitoring system for rheumatoid arthritis activity.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management